2009 annual financial data
Cellectar Biosciences 2009 Operating margin
Cellectar Biosciences 2009 operating margin with verified reported values.
Direct answer
Operating margin was -10,620.64%.
Operating income was -10,229,161 USD and net income was -22,273,306 USD.
Operating cash flow was -10,618,338 USD.
Get free Cellectar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 96,314 USD
- Operating income
- -10,229,161 USD
- Net income
- -22,273,306 USD
- Operating cash flow
- -10,618,338 USD